Vaccinating the elderly could have prevented some deaths in 2021, but the results were small. And even those small effects on mortality seem to vanish in the course of the booster program. This is the conclusion of our latest research, published in European Economic Review.
Most of Europe and the US have seen significant declines in COVID-related deaths. In mid-2021. Although this decline coincided with the rollout of the Covid vaccine, it has surprisingly proved difficult to pinpoint the extent to which vaccination contributed to the reduction in deaths.
Randomized controlled trials (the gold standard for testing latest treatments) suggest that COVID vaccination can provide significant protection against serious illness and death in comparison with individuals who haven't been previously vaccinated. Affected by COVID. But there are the explanation why vaccination's effect on mortality could also be small when checked out outside of trials.
At the start of this system, there have been hopes that vaccination would even be highly effective in stopping the spread of COVID, nevertheless it has since turn out to be clear that vaccination provides only limited and short-term protection against infection and transmission.
It can also be well established that previous infection confers protection against reinfection and against serious illness and death in cases of reinfection which are minimal. Effective as a vaccination. Having a major previous infection Reduces the chance of getting vaccinated. This implies that the vaccinated population will include a comparatively high proportion of people that could be unprotected from prior infection. So even when vaccination confers protection at the person level, we should still observe mortality rates on the population level which are similar for vaccinated and unvaccinated groups.
The effectiveness of vaccination programs will also be limited by people's attitudes. For example, there may be evidence that vaccinated individuals who develop an infection usually tend to have milder symptoms and subsequently be vaccinated. Less precautions than others against spreading infection. As a result, vaccination may sometimes be related to more slightly than less transmission.
Taken together, even when vaccination reduces risk on a person basis, it doesn't necessarily reduce mortality on the population level. Current research reflects this ambiguity with some empirical findings. Very important effects of vaccination on mortality While there have been other results Little or no effect.
Our latest study seeks to enhance our knowledge of the impact of COVID vaccination programs by assessing the impact of vaccination on deaths in care homes. This is a very essential group to look at. Given that the vast majority of COVID-related deaths occur within the elderly, any effect on mortality could also be more prone to be seen in care homes.
Mark Broxell/Almy Stock Photo
Machine learning used to research data
We checked out deaths from COVID in care homes in around 150 local authorities in England from the beginning of vaccine rollout in December 2020 until after the second booster dose in the summertime of 2022. Overall and deaths from COVID.
A feature of our research is using machine learning (a sort of artificial intelligence) to isolate the effect of vaccination from other aspects which have also affected mortality, including levels of prior infection in addition to between local authorities. Demographic, economic and health disparities are also included. .
Machine learning is especially adept at isolating the results of numerous potential explanatory variables, providing a lot better evidence of when associations represent true causal relationships. Unlike another research, we also use a measure of vaccination that takes under consideration the undeniable fact that effectiveness declines over time.
We found that higher vaccination rates of residents (but not staff) did result in lower mortality, however the effect was relatively small. For example, a ten% increase in resident vaccination uptake in a neighborhood authority led, on average, to a 1% reduction in total care home mortality. That equates to about 22 fewer deaths per week nationwide.
Of course, any reduction in deaths is welcome. But vaccination doesn't seem like a key think about reducing care home deaths from COVID. We also found that mortality reductions were limited to early vaccination rollouts.
Since September 2021, when the booster vaccination program began in England, over-vaccination of older residents doesn't appear to have reduced mortality. Based on these findings, it's unlikely that vaccination is chargeable for the continued decline in COVID-related deaths.
Then why did Europe and the US experience a big drop in deaths from COVID? From 2021Even when infection rates have increased?
There are two explanations for this. The first is the event of omicron-like variants that, although highly contagious, are less lethal than the variants chargeable for the initial waves.
Second, there may be a rise in the general number of people that have acquired protection from previous infections.
These descriptions are consistent with the experience of locations resembling Hong Kong, New Zealand and Taiwan. All saw relatively low COVID infections and deaths in 2020, meaning only limited levels of natural immunity had developed. All then experienced high mortality rates during 2022, when most individuals in those places had been vaccinated.
For example, Hong Kong reached a seven-day average mortality rate. 40 deaths per million in March 2022far higher than the best peak seen within the U.S. during your entire pandemic, despite overall vaccination rates being the identical at the moment.
Although vaccination could have barely reduced care home deaths within the initial rollout period, there may be little evidence that the booster program has had a major impact on COVID-related deaths.